Express Scripts on board with Novo's Ozempic; shares ahead 2% [Seeking Alpha]
EXPRESS SCRIPTS (ESRX)
Last express scripts earnings: 10/31 04:11 pm
Check Earnings Report
US:NASDAQ Investor Relations:
expressscriptsholdingco.gcs-web.com/investor-overview
Company Research
Source: Seeking Alpha
Express Scripts on board with Novo's Ozempic; shares ahead 2%Novo Nordisk (NVO+2%) is up more than a 40% spike in volume on the heels of the news that Express Scripts has added once-weekly type 2 diabetes med Ozempic (semaglutide) to its 2018 formulary, thereby establishing head-to-head competition with Eli Lilly's once-weekly Trulicity (dulaglutide), a situation enthusiastically embraced by the price hawkish pharmacy benefit manager.According toReuters, a Novo spokesperson stated that inclusion in Express Scripts' formulary should give Ozempic a "single-digit share" of the overall GLP-1 market in the U.S.Both products will also compete against AstraZeneca's once-weekly BYDUREON (exenatide).See all stocks on the move »Now read:Novo Nordisk: Obesity Crisis Could Be Profitable »
Show less
Read more
Impact Snapshot
Event Time:
ESRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ESRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ESRX alerts
High impacting EXPRESS SCRIPTS news events
Weekly update
A roundup of the hottest topics